IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $29,444,000 | -30.8% | 930,000 | +1.4% | 6.08% | -12.0% |
| Q4 2020 | $42,569,000 | -66.6% | 917,427 | -76.3% | 6.91% | -39.8% |
| Q3 2020 | $127,618,000 | +24.8% | 3,876,600 | +4.1% | 11.48% | +40.5% |
| Q2 2020 | $102,251,000 | +43.1% | 3,724,976 | +56.0% | 8.17% | +9.5% |
| Q1 2020 | $71,473,000 | -48.5% | 2,387,606 | -52.4% | 7.47% | -38.2% |
| Q4 2019 | $138,820,000 | +39.7% | 5,015,175 | -8.2% | 12.09% | +32.4% |
| Q3 2019 | $99,387,000 | -99.9% | 5,460,803 | 0.0% | 9.13% | -38.6% |
| Q2 2019 | $133,899,000,000 | +252802.1% | 5,460,803 | -1.9% | 14.86% | +183.7% |
| Q1 2019 | $52,945,000 | +7.5% | 5,567,348 | 0.0% | 5.24% | -15.9% |
| Q4 2018 | $49,271,000 | +25.3% | 5,567,348 | +59.2% | 6.23% | +1.6% |
| Q3 2018 | $39,334,000 | -11.8% | 3,496,340 | +0.3% | 6.13% | -0.9% |
| Q2 2018 | $44,618,000 | -99.9% | 3,485,745 | +5.0% | 6.18% | -25.8% |
| Q1 2018 | $56,128,000,000 | +350700.0% | 3,321,173 | +66.1% | 8.34% | +205.3% |
| Q4 2017 | $16,000,000 | +3.2% | 2,000,000 | 0.0% | 2.73% | -9.5% |
| Q3 2017 | $15,500,000 | +1148.0% | 2,000,000 | +1083.3% | 3.02% | +1252.0% |
| Q2 2017 | $1,242,000 | – | 169,014 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |